Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
BMC Cancer ; 22(1): 1125, 2022 Nov 02.
Artigo em Inglês | MEDLINE | ID: mdl-36324133

RESUMO

BACKGROUND: Bilateral breast cancer (BBC), as well as ovarian cancer, are significantly associated with germline deleterious variants in BRCA1/2, while BRCA1/2 germline deleterious variants carriers can exquisitely benefit from poly (ADP-ribose) polymerase (PARP) inhibitors. However, formal genetic testing could not be carried out for all patients due to extensive use of healthcare resources, which in turn results in high medical costs. To date, existing BRCA1/2 deleterious variants prediction models have been developed in women of European or other descent who are quite genetically different from Asian population. Therefore, there is an urgent clinical need for tools to predict the frequency of BRCA1/2 deleterious variants in Asian BBC patients balancing the increased demand for and cost of cancer genetics services. METHODS: The entire coding region of BRCA1/2 was screened for the presence of germline deleterious variants by the next generation sequencing in 123 Chinese BBC patients. Chi-square test, univariate and multivariate logistic regression were used to assess the relationship between BRCA1/2 germline deleterious variants and clinicopathological characteristics. The R software was utilized to develop artificial neural network (ANN) and nomogram modeling for BRCA1/2 germline deleterious variants prediction. RESULTS: Among 123 BBC patients, we identified a total of 20 deleterious variants in BRCA1 (8; 6.5%) and BRCA2 (12; 9.8%). c.5485del in BRCA1 is novel frameshift deleterious variant. Deleterious variants carriers were younger at first diagnosis (P = 0.0003), with longer interval between two tumors (P = 0.015), at least one medullary carcinoma (P = 0.001), and more likely to be hormone receptor negative (P = 0.006) and HER2 negative (P = 0.001). Area under the receiver operating characteristic curve was 0.903 in ANN and 0.828 in nomogram modeling individually (P = 0.02). CONCLUSION: This study shows the spectrum of the BRCA1/2 germline deleterious variants in Chinese BBC patients and indicates that the ANN can accurately predict BRCA deleterious variants than conventional statistical linear approach, which confirms the BRCA1/2 deleterious variants carriers at the lowest costs without adding any additional examinations.


Assuntos
Neoplasias da Mama , Neoplasias Ovarianas , Humanos , Feminino , Neoplasias da Mama/patologia , Mutação em Linhagem Germinativa , Predisposição Genética para Doença , Proteína BRCA1/genética , Proteína BRCA2/genética , Neoplasias Ovarianas/patologia , Células Germinativas/patologia , Redes Neurais de Computação , China
2.
Sensors (Basel) ; 22(19)2022 Oct 03.
Artigo em Inglês | MEDLINE | ID: mdl-36236599

RESUMO

The B-dot sensor is a type of Rogowski coil widely used in the measurement of current. However, the accuracy of the B-dot for measuring aircraft high-frequency lightning current is greatly affected by factors such as numerical integration drift, high-frequency oscillation, and calibration. In this study, a new design and optimization for improving the B-dot measuring accuracy was carried out. To correct the drift of the numerical integral of the measurement signal in differential mode, the measuring current was reconstructed based on the nonlinear least squares method. The sensor was then optimized by isolating the sampling resistance and matching the impedance with a voltage follower. A low-cost coaxial loop calibration system was also designed to calibrate the high frequency and strong magnetic fields more accurately. Finally, the optimized B-dot sensor accuracy was greatly improved with a measuring range of 30 kA/m, an error of 3.1%, and a high-frequency response of 50 MHz. Our study greatly increases the accuracy of measuring aircraft high-frequency lightning current.

3.
Sci Total Environ ; 823: 153425, 2022 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-35090930

RESUMO

The research on the mechanism of combined air pollution in the Yangtze-Huaihe region, which is characterized by unique meteorological and geographical conditions and pollution emission characteristics, is still insufficient. We performed an experiment on key pollutants and an ozone formation study in Hefei, which is a pivotal city in the Yangtze-Huaihe region, from September 1 to 20, 2020. The aerosols retrieved via two-dimensional Multi-axis Differential Optical Absorption Spectroscopy (2D-MAX-DOAS) with a Boltzmann-shaped a priori profile had the best agreement with the results of Light Detection and Ranging (LIDAR) and sun-photometer measurements among the three typical a priori profiles (Gaussian, Boltzmann, and exponential shapes). The correlation coefficients of the near-surface gas concentrations retrieved using both 2D-MAX-DOAS and in situ measurements were 0.86 (NO2) and 0.61 (HCHO). The high NO2 and HCHO concentrations were observed at azimuths of 180° and 315° at heights of 0.8-1.5 km, and they may have been emitted by aircrafts. Importantly, the ratio of HCHO to NO2 during a typical pollution episode revealed that the factors controlling the O3 formation changed with altitude: VOCs (surface) to NOx (0.4 km) to transition (1.0 km) to VOCs (1.6 km). Moreover, the effect of VOCs on the O3 generation was stronger than that of NOx, especially in the downtown area of Hefei. When the ratio of HCHO to NO2 was 3.55-7.46, the ozone concentration in Hefei could be controlled well, especially at the optimal value of 5.50.


Assuntos
Poluentes Atmosféricos , Ozônio , Poluentes Atmosféricos/análise , China , Monitoramento Ambiental/métodos , Dióxido de Nitrogênio/análise , Ozônio/análise
4.
Int Immunopharmacol ; 99: 107929, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34343940

RESUMO

OBJECTIVE: To explore the effect of programmed death 1 (PD-1) inhibitor combined with apatinib on immune regulation and efficacy of the combined therapy in mice bearing gastric cancer (MBGC), and to provide a research basis for enhancing the benefit of immunotherapy in advanced gastric cancer (AGC). METHODS: MBGC were divided into normal saline group (group NS), apatinib group (group A), PD-1 inhibitors group (group B) and PD-1 inhibitors combined with apatinib group (group C). Tumor inhibition rates were calculated. Cytokine levels and expression of immune cells and molecules were detected, and the pathological manifestations of tumor tissues were observed. RESULTS: Group C had the smallest tumor volume (115.17 ± 16.08 mm3) with a tumor inhibition rate of 89.4% ± 0.69%, significantly increased levels of CD4+T and CD8+T cells in tumor tissues (P < 0.01), the down-regulated proportion of myeloid-derived suppressor cells (MDSCs) (P < 0.01), and levels of PD-1 of CD8+T cells (PD-1+CD8+T) (P < 0.01). There was no difference in the levels of PD-1+CD8+T, CD4+T cells, and MDSCs between groups B and C. Besides, combination therapy increased the levels of interleukin-2 (IL-2), interferon-gamma (IFN-γ), and tumor necrosis factor-ɑ (TNF-ɑ) in tumor tissue and serum. We also found that the anti-angiogenic effect of apatinib increased programmed death ligand-1 (PD-L1) levels, down-regulated vascular endothelial growth factor receptor 2 (VEGFR-2) levels, and induced an increase in the extent of tumor tissue necrosis. CONCLUSION: PD-1 inhibitors in combination with apatinib may help improve treatment outcomes and increase survival benefits in patients with AGC.


Assuntos
Antineoplásicos/química , Inibidores de Checkpoint Imunológico/química , Inibidores de Proteínas Quinases/química , Piridinas/química , Neoplasias Gástricas/tratamento farmacológico , Microambiente Tumoral/efeitos dos fármacos , Inibidores da Angiogênese/farmacologia , Animais , Antineoplásicos/farmacologia , Terapia Combinada , Citocinas/metabolismo , Feminino , Regulação da Expressão Gênica , Humanos , Inibidores de Checkpoint Imunológico/farmacologia , Camundongos , Células Supressoras Mieloides , Inibidores de Proteínas Quinases/farmacologia , Piridinas/farmacologia , Pele , Linfócitos T
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA